We are using CNNs, Phenotypic profiling and Autoencoders (AI methods) to analyze the mitochondria of senescent (zombie-type cells) vs. proliferating (normally dividing) cells in the hope of finding a consistent trait for senescence.
We are using antibody staining of keratinocytes (keratin-producing-cells) in patients with Epidermolysis Bullosa Simplex of the Dowling-Meara type (EBS-DM)- to discover changes to the cytoskeleton of the keratinocytes with heat shock.
Here at Biotein, we're always working to create something bigger and better than before. Now, we're working on one of our most impactful projects - with applications from curing Alzheimer's and Parkinson's - to every system in our body.
VP New Tech Discovery
@ AgeX Therapeutics
Principal Investigator @
Riabowol Lab, Calgary U
Co-Founder and CEO
@ Netramark Corp.